Announcements Trials
Browse Landscape

Status

Completed 3

Sponsor Class

OTHER 2NIH 1

Study Type

Interventional 38Observational 3

Sponsor

Cancer Type

Other solid neoplasm 4Thoracic 3Breast 3Gastrointestinal 2CNS 2Head & Neck 1Gynecologic 1Dermatologic 1

Conditions

Breast Neoplasms 3Neurotoxicity Syndromes 1Fatigue 1Breast Neoplasms, Male 1

Interventions

Surveys and Questionnaires 79Blood Specimen Collection 67palbociclib 40Trastuzumab 34Drug Therapy 30Letrozole 29Anastrozole 27Radiotherapy 26Immunohistochemistry 26Mastectomy, Segmental 22Amplified Fragment Length Polymorphism Analysis 22Fulvestrant 21Biopsy 21exemestane 20Tamoxifen 20Interviews as Topic 20Gene Expression Profiling 20Magnetic Resonance Spectroscopy 19ribociclib 18Specimen Handling 18Mastectomy 18Neoadjuvant Therapy 17Paclitaxel 16High-Energy Shock Waves 16Capecitabine 16trastuzumab deruxtecan 15Mammography 15Psychiatric Rehabilitation 14Polymerase Chain Reaction 13Observation 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Observational × Fluorodeoxyglucose F18 × Breast × Clear all
NCT00006421 2026-05-22

Breast Imaging Studies in Women at High Genetic Risk of Breast Cancer: Annual Follow-Up Study

National Institutes of Health Clinical Center (CC)

Completed
200 enrolled
Breast

Breast Neoplasms

NCT00755313 2017-11-24

Effects of Chemotherapy on the Brain in Women With Newly Diagnosed Early-Stage Breast Cancer

University of California, San Francisco

Completed
81 enrolled
Breast

Breast Neoplasms, Fatigue, Neurotoxicity Syndromes

NCT00362973 2016-12-28

PET Scans in Assessing Response To Treatment in Patients Receiving Hormone Therapy or Trastuzumab for Breast Cancer

University of Washington

Completed
42 enrolled
Breast

Breast Neoplasms, Breast Neoplasms, Male

Data powered by HemOnc (CC BY 4.0) Colophon âš¡